Form 4: Mesa Laboratories Director Acquires and Disposes of Shares in Recent Transaction
SEC Form 4 Filing
Director Mark Christopher Capone reports acquisition and disposal of Mesa Laboratories Inc. common stock and Restricted Stock Units (RSUs) on August 15, 2024.
Summary
- On August 15, 2024, Mark Christopher Capone, a director of Mesa Laboratories Inc., engaged in transactions involving the company's stock.
- Capone disposed of 724 shares of common stock.
- Capone also disposed of 724 Restricted Stock Units (RSUs) that vested on August 15, 2024.
- Additionally, Capone acquired 1,404 Restricted Stock Units (RSUs) that vest on August 15, 2025.
- Following these transactions, Capone directly owns 1,404 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions. There is no indication of positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company directors and officers.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by providing insight into director's holdings and sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of transaction involving common stock and Restricted Stock Units. |
| 08/15/2024 | RSUs that vest on August 15, 2024 were disposed of. |
| 08/15/2025 | RSUs that vest on August 15, 2025 were acquired. |
| 08/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.